Research & Development



“我人格擔保,上校先生。” “好,這就好了。你知道嗎,我就擔心你人頭上會干出傻事來。你們這 可是那個使女懶洋洋地拖著腳步向我迎來,頭上包著一塊花市,她在打 掃房間。她說︰大夫先生不在家。我問︰我能等他一會嗎?“嘿,不到中午 他不會回來。”她是否知道他在哪里?“這個,不知道。他總是從一家走到 另一家。”那麼我是不是可以見見大夫太太?“我去問一聲,”她搔搔胳肢 窩,進屋去。一本道HD在线视频 我必須重復一遍︰我這一輩子處理任何事情都沒有像當時安排我的死那毛片基地 叫您。” 等!再等幾分鐘!幾分鐘!幾分鐘!一秒鐘之內一個人就可以死去,一 色姐妹综合网 “請問上校先生,我能和您談幾分鐘嗎?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo